AGAH
AGAH is a German non-profit professional association running accredited training courses, biennial conferences, and expert meetings in clinical pharmacology and exploratory drug development for industry, CRO, academic, and regulatory professionals across Europe.
- Company typePrivate
- Founded1991
- HeadquartersHamburg, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
What AGAH does
AGAH (Arbeitsgemeinschaft für Angewandte Humanpharmakologie e.V., the Association for Applied Human Pharmacology) is a non-profit specialist medical-academic organization registered under German law at Amtsgericht Hamburg, founded in 1991 and headquartered at Goernestraße 30, Hamburg. It focuses on exploratory medicinal product development and human pharmacological research, serving clinical pharmacology professionals, clinical investigators, project leaders and managers, monitors, PhD students, study nurses, and regulatory and ethics committee representatives active in early-phase drug development. The organization operates no proprietary technology platform; its core offering is a portfolio of accredited educational and convening services.
The product portfolio comprises the biennial AGAH Conference, the annual PK/PD Expert Meeting (running since 1995, drawing 70-90 attendees), the PharmaTrain-recognized Introductory Course in Exploratory Medicines Development (Parts I online and II face-to-face, accredited for 3 ECTS), the AGAH Applied Course in Clinical Pharmacokinetics, the AGAH Applied Course in Data Management, a modular EUFEMED Certificate in Human Pharmacology delivered jointly with European partner societies, the Study Nurse Academy (founded 2000, certifying ~500 study nurses through 2018), and a digital Mebinar webinar series. Delivery is hybrid: face-to-face at German venues (SocraTec R&D Oberursel, Wilhelm-Kempf-Haus Wiesbaden, Leonardo Weimar) and digitally via Microsoft Teams and Zoom. Working groups include PK/PD Expert Meeting, Study Nurse Academy, Open Systems Pharmacology (OSP), and an Early Career Network.
Revenue mechanics are membership-fee and training-fee based. Pricing is tiered by member vs. non-member and by participant category (regular, junior scientist under 30, regulatory agency/ethics committee staff), with training courses exempt from VAT under German §4 para 22. Examples include EUR 950/750 for the Applied Course in Clinical Pharmacokinetics and EUR 2,800-3,200 for both parts of the Introductory Course. Event and webinar fees, publication contributions, and enterprise sponsorship (e.g., Bayer, WuXi AppTec, SGS Belgium, Celerion for the 2026 conference) supplement membership revenue. Go-to-market is event-driven: the organization reaches its audience through its website (agah.eu), email/newsletter, LinkedIn, EUFEMED federation cross-promotion, and its own congress, workshops, and Mebinars. Governance rests with an elected board (President Dr. Jörg Täubel, President-elect Dr. Robert Schultz-Heienbrok, Past President Dr. Joachim Höchel, Treasurer André Warnke, Secretary Nadja Faißt) and event management is outsourced to CSi Hamburg GmbH.
AGAH firmographics
Firmographics- Name
- AGAH
- Legal name
- Arbeitsgemeinschaft für Angewandte Humanpharmakologie e.V.
- Website
- https://agah.eu
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- AGAH is a German non-profit professional association running accredited training courses, biennial conferences, and expert meetings in clinical pharmacology and exploratory drug development for industry, CRO, academic, and regulatory professionals across Europe.
- Ownership category
- akta.pro rank
Where AGAH is headquartered
LocationHeadquarters
- HQ city
- Hamburg
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
AGAH business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales, Others
Revenue model
- Membership fees: Annual membership fees from individual professionals in clinical pharmacology, pharmaceutical industry, CROs, and academia.
- Training course fees: Revenue from specialized training programs including Applied PK courses (950 EUR regular/750 EUR member), Introductory Courses in Exploratory Medicines Development (Parts I+II: 2800-3200 EUR), and modular EUFEMED certificate courses.
- Event registration fees: Fees from conferences, workshops, PK/PD Expert Meetings, and mebinar (webinar) registrations. AGAH Conference 2026 sponsorships from pharmaceutical companies.
- Publication and guideline contributions: Revenue from publications, guideline commentaries, and educational materials for human pharmacology professionals.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | AGAH Applied Course in Clinical Pharmacokinetics |
| Unit Pricing | Multi-year contract | Introductory Course in Exploratory Medicines Development |
| Unit Pricing | Pay-as-you-go | AGAH Mebinar (webinar) registration |
| Unit Pricing | Multi-year contract | PK/PD Expert Meeting |
| Unit Pricing | Multi-year contract | AGAH Workshop: Toxic Truths and Dosing Dilemmas |
| Unit Pricing | Multi-year contract | AFPT Training Course (partner event) |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
AGAH product offering
Product offeringCore offering
AGAH is a non-profit registered association that provides specialized training courses, scientific conferences, expert meetings, webinars (mebinars), and publications focused on exploratory medicinal product development and human pharmacological research. Its offerings include the biennial AGAH Conference, the annual PK/PD Expert Meeting, the PharmaTrain-recognized Introductory Course in Exploratory Medicines Development, the Applied Course in Clinical Pharmacokinetics, the Study Nurse Academy certification program, and a modular EUFEMED Certificate in Human Pharmacology. Services are delivered to clinical investigators, pharmaceutical scientists, study nurses, regulatory authorities, and ethics committees across Germany and Europe.
Product overview
AGAH (Association for Applied Human Pharmacology) is a specialist medical-academic organization focused on exploratory medicinal product development and human pharmacological research. The organization provides a comprehensive portfolio of educational and professional services including: training courses (Introductory Course in Exploratory Medicines Development, Applied Course in Clinical Pharmacokinetics, Applied Course in Data Management, Modular Training Course in Human Pharmacology); recurring scientific events (Annual Conference held biennially, PK/PD Expert Meeting, AGAH Mebinar webinar series); professional development programs (Study Nurse Academy with certification); and publications. These services are designed for professionals working in early clinical development, clinical pharmacology, and translational medicine research.
Differentiator
Problem solved
Functional benefit
Brands
- Study Nurse Academy: Advanced training for study nurses and study assistants in clinical trials, including annual forums and certification programs.
- PK/PD Expert Meeting
- Open Systems Pharmacology (OSP)
Products and services
- AGAH Annual Conference Biennial scientific congress in Germany featuring scientific sessions, workshops, and panel discussions on exploratory medicinal product development and human pharmacology. Designed for clinical investigators, pharmaceutical scientists, and regulatory professionals.
- Introductory Course in Exploratory Medicines Development Two-part training course (Part I online, Part II face-to-face) providing an overview of Human Pharmacology and Translational Medicine, from non-clinical pharmacology through first-in-man studies to proof-of-concept clinical trials. PharmaTrain-recognized and 3 ECTS-accredited. Targeted at postgraduates in life sciences interested in early clinical development of medicinal products.
- AGAH Applied Course in Clinical Pharmacokinetics Two-day workshop offering entry to the physiological background, measures, and characteristics of pharmacokinetics. Designed for clinical investigators, project leaders, project managers, monitors, and PhD students in industry, CROs, and academia.
- AGAH Mebinar (Member Webinar Series) Digital seminar/webinar series covering current topics in human pharmacology, drug development, and clinical research including topics such as the placebo effect, electronic health records, pharmacovigilance, and AI in drug development. Open to both members and non-members.
- PK/PD Expert Meeting Annual expert meeting under AGAH auspices serving as a discussion forum for PK/PD scientists from industry, academia, and CROs. Held yearly with presentations covering PK/PD aspects of drug development and attracts approximately 70-90 participants mainly from German-speaking countries. Includes the Hans Günter Schäfer Award for young scientists.
- Study Nurse Academy Advanced training and certification program for study nurses, study assistants, and study coordinators. Provides specialist presentations, workshops, and forums on latest topics in clinical trials. Founded in 2000 and has certified approximately 500 study nurses through 2018.
- Modular Training Course in Human Pharmacology (EUFEMED Certificate) European modular training program developed in cooperation with EUFEMED and partner societies (AFPT, Healixia), leading to a Certificate in Human Pharmacology. Includes modules on regulatory issues, ethics, GxP, quality assurance, pharmacokinetics, pharmacodynamics, and biomarkers, with sessions held at KU Leuven and UGent.
- AGAH Applied Course in Data Management Workshop on clinical data management principles in early-phase trials, covering CDISC standards, database setup, and regulatory data submission requirements.
- AGAH Publications Selection of publications, research results, and guideline commentaries produced with AGAH collaboration, covering human pharmacology and early clinical development topics. Published in partnership with Naunyn-Schmiedeberg's Archives of Pharmacology.
- AGAH Membership Annual membership for individual professionals in clinical pharmacology, pharmaceutical industry, CROs, and academia. Membership provides free access to mebinars, reduced fees for training courses and events, and access to member-only resources and networking.
Quantifiable outcome
- PharmaTrain Recognition awarded to Introductory Course in Exploratory Medicines Development (Parts I and II)
- +1 more outcomes
Companies that use AGAH
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles3 records
AGAH technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AGAH partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- EUFEMED (European Federation for Exploratory Medicines Development)coreAGAH is a member society of EUFEMED, the European Federation for Exploratory Medicines Development. Together with AFPT (France), AHPPI (UK), BAPU (Belgium), Healixia (Belgium), Polfemed (Poland), and ACRON (Netherlands), AGAH participates in the EUFEMED Certificate in Human Pharmacology modular training program. EUFEMED organizes conferences and joint training activities across Europe.
- AHPPI (Association of Human Pharmacology in the Pharmaceutical Industry)coreBritish partner organization with which AGAH holds joint scientific events in alternating years. AHPPI is one of the founding associations of EUFEMED.
- BAPU (Belgian Association of Phase I Units)coreBelgian partner organization with which AGAH holds joint scientific events. Also known in sources as 'Bapu'.
- AFPT - Le Club Phase I (Association Française de Pharmacologie Translationnelle)coreFrench partner organization with which AGAH holds joint scientific events. AFPT organizes training courses on pre-clinical and clinical safety in early development human trials in cooperation with EUFEMED.
- BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)minorGerman Federal Institute for Drugs and Medical Devices. AGAH holds an annual national discussion round together with BfArM, where mostly safety-relevant matters in early-phase clinical studies are discussed.
- HealixiacoreBelgian association for exploratory medicines development. Co-organizes Module 4 (PK/PD/Biomarkers) of the EUFEMED Certificate in Human Pharmacology training program, with sessions held at KU Leuven and UGent.
- Polfemed (Polish Federation for Early Medicines Development)corePolish partner organization. Member of EUFEMED federation. Organized EUFEMED Workshop on Investigator's Brochure in 2024 in Warsaw.
- ACRON (Associatie van Contract Research Organisaties in Nederland)coreDutch association of contract research organizations. Member of EUFEMED federation.
- CSi Hamburg GmbHminorEvent management company handling logistics and organization for AGAH meetings, conferences, and member communications. Located at Goernestraße 30, 20249 Hamburg.
- SocraTec R&D GmbHminorConsulting partner providing speakers and expertise for AGAH training courses and mebinars. Located at Im Setzling 35, 61440 Oberursel.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
AGAH competitors and assessment
Company assessmentDirect peers
- Healixia: Belgian association for exploratory medicines development that co-organizes Module 4 (PK/PD/Biomarkers) of the EUFEMED Certificate in Human Pharmacology with AGAH. Directly comparable member-based association serving clinical pharmacology professionals in Belgium.
- AHPPI (Association of Human Pharmacology in the Pharmaceutical Industry): British sister organization that AGAH co-organizes alternating biennial scientific events with; AHPPI is a founding member of EUFEMED and serves the same UK-based clinical pharmacology professional community, making it the closest geographic peer to AGAH's UK-facing work.
- BAPU (Belgian Association of Phase I Units): Belgian partner organization for Phase I unit operators that AGAH holds joint scientific events with. Serves the same early-phase clinical pharmacology community in Belgium and is a co-founding member of EUFEMED.
- AFPT - Le Club Phase I (Association Française de Pharmacologie Translationnelle): French counterpart focused on translational pharmacology and pre-clinical/clinical safety in early development human trials. AGAH alternates biennial joint events with AFPT and both co-organize training through EUFEMED.
- ASCPT (American Society for Clinical Pharmacology & Therapeutics): Leading US-based professional society for clinical pharmacology and therapeutics; operates annual meetings, journals, and continuing education for clinical pharmacologists. Comparable in mission (clinical pharmacology professional development) and member-driven model, though much larger in scope and scale than AGAH.
- ACCP (American College of Clinical Pharmacology): US professional society dedicated to clinical pharmacology education, certification, and annual meetings. Closely comparable mission in advancing clinical pharmacology through education, training programs, and member-driven activities, though with broader scope and significantly larger scale than AGAH.
Regional players
- ACRON (Associatie van Contract Research Organisaties in Nederland): Dutch association of contract research organizations and EUFEMED member. Complementary regional peer serving Dutch clinical research and early-phase trial professionals with similar event-based and training-driven engagement model.
- Polfemed (Polish Federation for Early Medicines Development): Polish federation and EUFEMED member society focused on early medicines development. Organized the EUFEMED Workshop on Investigator's Brochure in 2024 in Warsaw; operates as a comparable regional counterpart serving Polish clinical pharmacology professionals.
Others
- EUFEMED (European Federation for Exploratory Medicines Development): Umbrella European federation that AGAH belongs to along with national societies (AHPPI, BAPU, AFPT, Healixia, Polfemed, ACRON). Coordinates the modular Certificate in Human Pharmacology training program and joint conferences across member countries.
Emerging players
- ACRP (Association of Clinical Research Professionals): Global not-for-profit membership organization for clinical research professionals that offers certification, training, and educational programming. Overlaps with AGAH's Study Nurse Academy focus on research coordinator certification, though ACRP's scope extends beyond early-phase clinical pharmacology.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
AGAH social profiles
Digital presenceAGAH financial estimates
Financial estimateRevenue estimate
Valuation estimate
AGAH leadership team
Management profileNumber of profiles
Profiles5 records
AGAH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AGAH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AGAH
What does AGAH do?
AGAH is a non-profit registered association that provides specialized training courses, scientific conferences, expert meetings, webinars (mebinars), and publications focused on exploratory medicinal product development and human pharmacological research. Its offerings include the biennial AGAH Conference, the annual PK/PD Expert Meeting, the PharmaTrain-recognized Introductory Course in Exploratory Medicines Development, the Applied Course in Clinical Pharmacokinetics, the Study Nurse Academy certification program, and a modular EUFEMED Certificate in Human Pharmacology. Services are delivered to clinical investigators, pharmaceutical scientists, study nurses, regulatory authorities, and ethics committees across Germany and Europe.
Is AGAH a public or private company?
AGAH is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was AGAH founded?
AGAH was founded in 1991. It employs 11 to 50 people.
Where is AGAH based?
AGAH is headquartered in Hamburg, Germany, in the Europe region.
How does AGAH make money?
Four revenue lines are on record. Membership fees are the primary driver. The others are training course fees, event registration fees and publication and guideline contributions.
Who are AGAH's main competitors?
Direct peers on record are Healixia, AHPPI (Association of Human Pharmacology in the Pharmaceutical Industry), BAPU (Belgian Association of Phase I Units), AFPT - Le Club Phase I (Association Française de Pharmacologie Translationnelle), ASCPT (American Society for Clinical Pharmacology & Therapeutics) and ACCP (American College of Clinical Pharmacology). Regional players are ACRON (Associatie van Contract Research Organisaties in Nederland) and Polfemed (Polish Federation for Early Medicines Development). EUFEMED (European Federation for Exploratory Medicines Development) is listed as an others. ACRP (Association of Clinical Research Professionals) is listed as an emerging player.
Does AGAH have an API?
No public API is recorded for AGAH.